Skip to content
Medical Health Aged Care

InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record

InterSystems 3 mins read

New Platform Leverages the Latest AI Technology to Enhance Clinician Workflows and Optimize Operations for Healthcare Enterprises


BOSTON & LAS VEGAS--BUSINESS WIRE--

InterSystems, a creative data technology provider managing over one billion health records globally, today announced the launch of InterSystems IntelliCare, an AI-powered electronic health record (EHR) and healthcare information system designed to fundamentally change the way clinicians, administrators, and patients engage with healthcare technology.

Introduced at HIMSS25, IntelliCare brings next-generation AI capabilities to EHRs, delivering streamlined workflows, reduced administrative burden, enhanced patient interactions, and improved operational efficiency—all while maintaining rigorous human oversight for accuracy and safety. Built on InterSystems industry-proven TrakCare electronic medical record, IntelliCare is designed specifically for healthcare systems undergoing rapid digital transformation and seeking modern, seamlessly connected solutions without the constraints of legacy systems.

“IntelliCare represents the next step in the evolution of EHRs,” said Don Woodlock, head of global healthcare solutions at InterSystems. “By building an EHR solution with AI at its core, we’re helping healthcare providers focus on what matters: More face time with patients and less screen time.”

“AI is a seismic shift in healthcare technology,” said Jusup Halimi, President Director of EMC Healthcare. “With its advanced AI functionality and decades of proven reliability, InterSystems IntelliCare was the obvious choice to provide our hospitals with the most advanced solution available.”

InterSystems IntelliCare will streamline the EHR experience by integrating AI-driven intelligence across clinical, administrative, and financial workflows. Healthcare systems leveraging IntelliCare can benefit from:

  • AI-Driven Efficiency. IntelliCare harnesses generative AI to eliminate administrative inefficiencies, allowing clinicians to spend more time interacting with patients instead of navigating complex data entry screens. Its AI Assistant enables natural language commands and automatic patient history summarization.
  • Enhanced Patient Engagement. IntelliCare fosters more natural interactions between patients and providers by removing the need for data entry during office visits. With real-time capture and generation of encounter notes powered by ambient listening and AI-driven documentation tools, clinicians can focus on meaningful conversations with their patients instead of being bogged down by note-taking during visits.
  • Optimized Healthcare Operations. Designed to support healthcare administrators and IT teams, IntelliCare streamlines workflows, reduces operational inefficiencies, and facilitates interoperability between systems. Using AI to prepopulate the codes required for billing within the end-to-end revenue cycle management solution helps optimize financial operations and reduce errors while accelerating reimbursement cycles.
  • A Future-Ready EHR. Unlike legacy systems, IntelliCare is built with interoperability at its core, seamlessly integrating with existing healthcare IT infrastructures. The solution is available for on-premises, cloud, or SaaS deployment, ensuring flexibility for organizations of all sizes.

InterSystems IntelliCare is available now in the Middle East, Oceania, Latin American, and Southeast Asian markets. InterSystems will showcase IntelliCare at HIMSS25, offering attendees a firsthand look at its AI-powered capabilities. For a full schedule of InterSystems HIMSS25 activities or to coordinate a meeting, please visit: www.intersystems.com/himss/#meet-with-us

About InterSystems

InterSystems, a creative data technology provider, delivers a unified foundation for next-generation applications for healthcare, finance, manufacturing, and supply chain customers in more than 80 countries. Our data platforms solve interoperability, speed, and scalability problems for large organizations around the globe to unlock the power of data and allow people to perceive data in imaginative ways. Established in 1978, InterSystems is committed to excellence through its 24×7 support for customers and partners around the world. Privately held and headquartered in Boston, Massachusetts, InterSystems has 38 offices in 28 countries worldwide. For more information, please visit InterSystems.com.


Contact details:

Zach Keating
[email protected]
+1 617-621-0700

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.